RenovoRx, Inc. (RNXT): Price and Financial Metrics

RenovoRx, Inc. (RNXT): $1.19

0.08 (+7.21%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add RNXT to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#121 of 429

in industry

RNXT Price/Volume Stats

Current price $1.19 52-week high $2.35
Prev. close $1.11 52-week low $0.53
Day low $1.13 Volume 251,500
Day high $1.24 Avg. volume 44,854
50-day MA $1.04 Dividend yield N/A
200-day MA $1.21 Market Cap 28.56M

RNXT Stock Price Chart Interactive Chart >


RenovoRx, Inc. (RNXT) Company Bio


RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Los Altos, California.


RNXT Latest News Stream


Event/Time News Detail
Loading, please wait...

RNXT Latest Social Stream


Loading social stream, please wait...

View Full RNXT Social Stream

RNXT Price Returns

1-mo 19.00%
3-mo 17.85%
6-mo -5.56%
1-year 83.36%
3-year -81.44%
5-year N/A
YTD -48.03%
2023 -2.55%
2022 -51.45%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!